PELOTON PHARMACEUTICALS
PELOTON PHARMACEUTICALS
Industry:
Cannabis Pharmaceutical
Founded:
2013-01-01
Address:
Pointe-claire, Quebec, Canada
Country:
Canada
Status:
Active
Similar Organizations
Masaya Medical
Pharmaceutical-grade cannabis
More informations about "Peloton Pharmaceuticals"
Merck to Acquire Peloton Therapeutics, Bolstering …
May 21, 2019 Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Peloton Therapeutics, Inc. today announced that the companies have entered into a definitive agreement under which Merck, through a …See details»
Peloton Pharmaceuticals - Crunchbase Company Profile & Funding
Frequently Asked Questions Where is Peloton Pharmaceuticals's headquarters? Peloton Pharmaceuticals is located in Pointe-claire, Quebec, Canada. Who are Peloton …See details»
Aurora to Acquire Peloton Pharmaceuticals Inc. - Newswire
Mar 6, 2017 Peloton is constructing a 40,000 square foot cannabis production facility in Pointe Claire, Quebec, which received a "ready to build" letter from Health Canada in 2014.See details»
Peloton Pharmaceuticals Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Peloton Pharmaceuticals Inc of Pointe-Claire, QC. Get the latest business insights from Dun & Bradstreet.See details»
Peloton Pharmaceuticals 2025 Company Profile: Valuation, …
Information on acquisition, funding, investors, and executives for Peloton Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Acquisition de Pharmaceutiques Peloton inc. par …
Dans le cadre de son processus de restructuration en vertu de la Loi sur la faillite et l’insolvabilité, Pharmaceutiques Peloton inc. (« Peloton ») a vendu ses actifs à Aurora Cannabis inc., une société ouverte inscrite à la cote de la Bourse de …See details»
PELOTON PHARMACEUTICALS INC. / PHARMACEUTIQUES …
PELOTON PHARMACEUTICALS INC. / PHARMACEUTIQUES PELOTON INC. is a Non-distributing corporation with 50 or fewer shareholders corporation type, which located at 2800, …See details»
Peloton Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Peloton Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Peloton Pharmaceuticals Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Peloton Pharmaceuticals Inc. of Edmonton, AB. Get the latest business insights from Dun & Bradstreet.See details»
Peloton Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Nov 14, 2024 Explore Peloton Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Peloton Pharmaceuticals - Ownership and Business Overview
Peloton Therapeutics, Inc. is a clinical-stage biotechnology company that discovers and develops first-in-class, small molecule cancer therapies targeting unexploited molecular vulnerabilities.See details»
Acquisition of Peloton Pharmaceuticals by Aurora Cannabis
In the context of its restructuring process under the Bankruptcy and Insolvency act, Peloton Pharmaceuticals Inc. (“Peloton”) sold its assets to Aurora Cannabis Inc., a publicly traded …See details»
PELOTON PHARMACEUTICALS INC. - Bizapedia
Apr 19, 2025 Discover Company Info on PELOTON PHARMACEUTICALS INC. in 2800, 10104-103 AVENUE EDMONTON AB T5J 0H8, such as Contacts, Addresses, Reviews, and …See details»
Peloton Therapeutics Company Profile - Office Locations ... - Craft
See insights on Peloton Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Peloton Pharmaceuticals - 2025 Company Profile - Tracxn
Jun 3, 2025 Peloton Pharmaceuticals is an acquired company based in Pointe-claire (Canada), founded in 2013. It operates as a Provider of cannabis production services. The company has …See details»
Merck signs $1bn deal to acquire Peloton Therapeutics
Merck has signed a definitive agreement to acquire biopharmaceutical company Peloton Therapeutics for an upfront payment of $1.05bn. The deal includes an additional $1.15bn in …See details»
Merck buys Peloton to expand its kidney cancer treatment portfolio
U.S. drugmaker Merck & Co Inc on Tuesday agreed to buy Peloton Therapeutics Inc for $1.05 billion in cash, gaining access to the privately held company's lead kidney cancer drug candidate.See details»
Merck & Co to buy cancer biotech Peloton for $2.2bn
Jun 4, 2025 Merck & Co is to buy the privately-held biotech Peloton for up to $2.2 billion, adding further oncology drugs to its pipeline.See details»
Peloton Therapeutics Inc. - UT Southwestern Medical Center
Founded in 2011, Peloton Therapeutics Inc. is an oncology drug discovery and development company advancing first-in-class small molecule therapies that provide patients suffering from …See details»
Navigating the Pipeline: Alum Drives Drug Development at Eli Lilly
1 day ago June 16, 2025 · Muhammad Baluom, PhD, an executive director of clinical pharmacology at Eli Lilly and Company, reflects on his journey from becoming a pharmacist in …See details»